Cannabidiol in Pancreatic Ductal Adenocarcinoma: Preclinical Evidence, Molecular Mechanisms, and Translational Challenges

The authors evaluate the preclinical and early clinical evidence regarding cannabidiol’s anticancer effects in PDAC, with emphasis on its molecular mechanisms, therapeutic synergies, and translational feasibility.